Evidence map›Paper›PMID 20551291›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2010

Quercetin potentiates UVB-Induced c-Fos expression: implications for its use as a chemopreventive agent.

Erik R Olson, Tania Melton, Sally E Dickinson, Zigang Dong, David S Alberts, G Tim Bowden

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Phytochemicals for the Prevention of Photocarcinogenesis.Photochemistry and photobiology · 2017
    Review
  4. Article
  5. Quercetin modulates keratoconus metabolism in vitro.Cell biochemistry and function · 2015
    Article
  6. Review
  7. Quercitrin protects skin from UVB-induced oxidative damage.Toxicology and applied pharmacology · 2013
    Article
  8. Review
  9. Natural agents: cellular and molecular mechanisms of photoprotection.Archives of biochemistry and biophysics · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Erik R OlsonArizona Cancer Center, University of Arizona, Tucson, USA. eolson@azcc.arizona.edu
Tania Melton
Sally E Dickinson
Zigang Dong
David S Alberts
G Tim Bowden
University of Minnesota · USUniversity of Arizona · USHormel (United States) · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
VITAMIN A, AND ITS PRECURSORS AND DERIVATIVES AS THERAPEUTIC MODALITIESP01CA027502 · NCI · UNIVERSITY OF ARIZONA · PI STRATTON, STEVEN P · 1985 to 2015
$36.3M
Cancer Prevention and Control Translational ResearchR25CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL · 1998 to 2014
$7.6M
Cancer Prevention and Control Health Disparities Training ProgramT32CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL, HARRIS, ROBIN B · 2016 to 2020
$1.2M
Prevention of UVB-induced skin cancer using sulforaphane: roles of AP-1 and Nrf2.K07CA132956 · NCI · UNIVERSITY OF ARIZONA · PI DICKINSON, SALLY E · 2008 to 2012
$671k
NCI NIH HHS CA23074NCI NIH HHS CA27502NCI NIH HHS CA78447NCI NIH HHS K07 CA132956NCI NIH HHS P01 CA027502NCI NIH HHS P30 CA023074NCI NIH HHS R25 CA078447NCI NIH HHS T32 CA078447NIEHS NIH HHS ES06694NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

Quercetin (Qu) is currently being investigated as a chemopreventive agent for several cancers, including nonmelanoma skin cancer induced by UV light. We previously reported that Qu degradation has important consequences on signaling and cell biology. In the current study, we report that Qu induces c-Fos mRNA and protein expression through activation of p38 and cAMP-responsive element binding protein (CREB), and Qu potentiates UVB-induced c-Fos expression. Inclusion of ascorbic acid (AA) in cell culture medium stabilizes Qu and completely prevents both Qu- and UVB-induced p38 and CREB activation, leading to a blockade of c-fos gene expression through reduced CREB/cAMP-responsive element binding. AA stabilizes c-Fos mRNA, increasing steady-state levels even when c-fos gene expression is suppressed, but this has no effect on c-Fos protein levels in either mock- or UVB-irradiated cells. We report that Qu blocks mammalian target of rapamycin signaling and inhibits c-Fos protein expression directly through this mechanism because cotreatment with Qu and AA resulted in the complete suppression of UVB-induced c-Fos protein expression even in the presence of significantly increased mRNA levels. We further confirmed that this was not due to increased protein turnover because inhibition of proteasome activity with MG-132 did not raise c-Fos protein levels in Qu+AA-treated cells. Together, these data indicate that although Qu has been reported to have some beneficial properties as a chemopreventive agent, it is also capable of inducing c-fos expression, a cellular event important for the promotion phase of tumor development, if it is not stabilized.

Indexed as

Ultraviolet RaysAnticarcinogenic AgentsAscorbic AcidCell LineCyclic AMP Response Element-Binding ProteinDrug StabilityHumansIntracellular Signaling Peptides and ProteinsKeratinocytesp38 Mitogen-Activated Protein KinasesPhosphorylationProtein Serine-Threonine KinasesProto-Oncogene Proteins c-fosQuercetinSkin NeoplasmsTOR Serine-Threonine KinasesAnticarcinogenic AgentsAscorbic AcidCyclic AMP Response Element-Binding ProteinIntracellular Signaling Peptides and ProteinsMTOR protein, humanp38 Mitogen-Activated Protein KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-fosQuercetinTOR Serine-Threonine Kinases

Identifiers

PMID20551291
PMCPMC2925138
OpenAlexW2146092806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.